Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
From the editor in chief
Drug companies make millions on lifestyle potions. Is R&D on more vital therapies lagging?
A vial of bacteria capable of computation? Injectable cells that survey the bloodstream and produce drugs on demand? These ideas might not be as far-fetched as they sound.
For thousands of years, people have interacted through speech and gesture. Truly easy-to-use machines will do the same.
Alternatives to silicon-based computing are long shots. Knowing that, why do HP, Lucent and IBM spend time and money pursuing them? Their reasons may surprise you.
A DNA mismatch raises fears.
Bioengineers grow a circulatory system on silicon.
Here’s a little secret: Although you may think you own the software that you have paid good money for, you don’t.